Use this url to cite publication: https://hdl.handle.net/20.500.14172/24450
Options
Improvement of survival over time for colorectal cancer patients: a population-based study
Type of publication
Straipsnis Web of Science ir Scopus duomenų bazėje / Article in Web of Science and Scopus database (S1)
Type of document
type::text::journal::journal article::research article
Author(s)
Dulskas, Audrius | Nacionalinis vėžio institutas | Vilniaus universitetas | ||||
Gaižauskas, Vytautas | Vilniaus universiteto ligoninė Santaros klinikos | |||||
Kildušienė, Inga | Nacionalinis vėžio institutas | |||||
LT | Vilniaus universitetas | LT | Klaipėdos universitetinė ligoninė | LT | ||
Smailytė, Giedrė | Nacionalinis vėžio institutas | Vilniaus universitetas |
Title
Improvement of survival over time for colorectal cancer patients: a population-based study
Publisher
Basel : MDPI
Date Issued
Date Issued | Volume | Issue | Start Page | End Page |
---|---|---|---|---|
2020-12-08 | vol. 9 | iss. 12, art. no. 4038 | 1 | 9 |
Is part of
Journal of clinical medicine
Field of Science
Abstract
Purpose: In this study, we analyzed the mortality and survival of colorectal cancer patients in Lithuania. Methods: This was a national cohort study. Population-based data from the Lithuanian Cancer Registry and period analyses were collected. Overall, 20,980 colorectal cancer patients were included. We examined the changes in colorectal cancer mortality and survival rates between 1998 and 2012 according to cancer anatomical sub-sites and stages. We calculated the 5-year relative survival estimates using period analysis. Results: Overall, 20,980 colorectal cancer cases reported from 1998 to 2012 were included in the study. The total number of newly diagnosed colorectal cancers increased from 1998–2002 to 2008–2012 by 12.1%. The highest number of colorectal cancers was localized and increased from 33.9% to 42.0%. The number of cancers with regional metastases and advanced cancers decreased by 11.1% and 15.5%, respectively. An increased number of new cases was observed for almost all colon cancer sub-sites. The overall 5-year relative survival rate increased from 37.9% in 1998–2002 to 51.5% in 2008–2012. We showed an increase in survival rates for all stages and all sub-sites. In the most recent period, patients with a localized disease had a 5-year survival rate of 78.6%, while survival estimates for advanced cancer patients remained low at 6.6%. Conclusion: Although survival rates variated in colorectal cancer patients according to disease stages and sub-sites, we showed increased survival rates for all patients.
Is Referenced by
ISSN (of the container)
2077-0383
WOS
000601972100001
Scopus
2-s2.0-85114273532
PubMED
33327538
eLABa
78223449
Coverage Spatial
Šveicarija / Switzerland (CH)
Language
Anglų / English (en)
Bibliographic Details
31
Date Reporting
2020
Access Rights
Atviroji prieiga / Open Access
File(s)
Journal | IF | AIF | AIF (min) | AIF (max) | Cat | AV | Year | Quartile |
---|---|---|---|---|---|---|---|---|
Journal of Clinical Medicine | 4.241 | 5.181 | 5.181 | 5.181 | 1 | 0.819 | 2020 | Q1 |
Journal | IF | AIF | AIF (min) | AIF (max) | Cat | AV | Year | Quartile |
---|---|---|---|---|---|---|---|---|
Journal of Clinical Medicine | 4.241 | 5.181 | 5.181 | 5.181 | 1 | 0.819 | 2020 | Q1 |